The same review stresses that settings matter as much as the device: pulse duration, fluence and spot size are adjusted to the skin type and the treatment endpoint.10
Redness and vessels. A GRADE-rated review of rosacea trials found low-to-moderate-certainty evidence for laser and IPL on erythema and mainly telangiectasia.11 A 2026 review found pulsed dye laser or IPL improved telangiectasias linked to systemic sclerosis or lupus in all 10 studies it included, although more sessions may be needed.12
Post-acne redness. Among 9 randomized trials, picosecond alexandrite laser and narrow-spectrum IPL showed favourable effects against untreated skin, and narrow-spectrum IPL was favoured over broad-spectrum IPL. Small samples and short follow-up prevented the authors naming a preferred treatment.15
Photoaging. In a retrospective study of 50 patients with Fitzpatrick types III to IV, three monthly Q-switched 1064 nm sessions lowered the mean wrinkle score from 4.54 to 3.42. The authors note there was no control group.13
Melasma. A 2026 review says IPL, photobiomodulation and several lasers show promise but no single modality is definitive. Combinations with topical or oral agents work better, and maintenance is crucial.14